LifeGoal Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$578K Buy
482
+17
+4% +$17.4K 0.26% 54
2026
Q1
$444K Buy
465
+230
+98% +$233K 0.25% 58
2025
Q4
$253K Sell
235
-29
-11% -$27.7K 0.17% 66
2025
Q3
$201K Buy
264
+3
+1% +$2.23K 0.17% 69
2025
Q2
$203K Sell
261
-20
-7% -$15.5K 0.19% 64
2025
Q1
$232K Hold
281
0.25% 56
2024
Q4
$217K Buy
+281
New +$233K 0.24% 57

Other funds holding LLY

LifeGoal Wealth Advisors's LLY Position: Q2 2026 in Review

LifeGoal Wealth Advisors increased its Eli Lilly (LLY) stake by 3.7% in Q2 2026, buying an estimated $17.4K and bringing the position to 482 shares worth $578K. The position accounts for 0.26% of the portfolio, ranked #54.

LifeGoal Wealth Advisors first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,592 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • LifeGoal Wealth Advisors held 482 shares of Eli Lilly worth $578K as of Q2 2026.
  • LifeGoal Wealth Advisors bought 17 Eli Lilly shares in Q2 2026, an estimated $17.4K.
  • Eli Lilly made up 0.26% of LifeGoal Wealth Advisors's portfolio in Q2 2026, its #54 holding.
  • LifeGoal Wealth Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 1,592 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on LifeGoal Wealth Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.